Screener
Astrana Health ASTH Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Astrana Health in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Astrana Health’s 10-Q, filed May 8, 2026.
- Filed
- May 8, 2026, 6:01 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-213157
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 15,479 | 6,849 |
| Amortization of debt issuance cost | 1,134 | 691 |
| Share-based compensation | 9,895 | 7,811 |
| Non-cash lease expense | 2,005 | 1,287 |
| Deferred tax | 1,907 | (358) |
| Change in fair value of contingent consideration liabilities | 581 | 1,407 |
| Other | (2,564) | 729 |
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Astrana Health's stock-based comp?
- Astrana Health (ASTH) reported stock-based comp of $9.9M in Q1 2026.
- How has Astrana Health's stock-based comp changed year-over-year?
- Astrana Health's stock-based comp increased by 26.7% year-over-year, from $7.81M to $9.9M.
- What is the long-term trend for Astrana Health's stock-based comp?
- Over 4 years (2021 to 2025), Astrana Health's stock-based comp has grown at a 54.7% compound annual growth rate (CAGR), from $6.75M to $38.6M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about Astrana Health's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude